Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Burkitt Lymphoma 23Lymphoma, Large B-Cell, Diffuse 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Follicular 12Lymphoma 11Rhabdomyosarcoma 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Biphenotypic, Acute 7Recurrence 6Lymphoma, Non-Hodgkin 6Lymphoma, B-Cell 6Wilms Tumor 5Sarcoma, Ewing 5Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Rhabdomyosarcoma, Embryonal 3Medulloblastoma 3Lymphoproliferative Disorders 3Lymphoma, T-Cell 3Down Syndrome 3Sarcoma 2Rhabdomyosarcoma, Alveolar 2Rhabdoid Tumor 2Plasmablastic Lymphoma 2Osteosarcoma 2

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PRETEXT I Hepatoblastoma × Vincristine × 90 days × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡